financetom
Business
financetom
/
Business
/
Australian insurer QBE taps RiverStone, Enstar to de-risk $1.6 bln reserves exposure
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Australian insurer QBE taps RiverStone, Enstar to de-risk $1.6 bln reserves exposure
Aug 8, 2024 3:22 PM

Aug 9 (Reuters) - Australia's QBE Insurance ( QBEIF ) on

Friday said it had entered reserve transactions with RiverStone

International and Enstar ( ESGR ) in a bid to de-risk the firm's

exposure to reserves totalling $1.6 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: United Airlines Deal Almost Doubles SpaceX's Starlink In-Flight Wi-Fi Orders
Market Chatter: United Airlines Deal Almost Doubles SpaceX's Starlink In-Flight Wi-Fi Orders
Sep 17, 2024
01:43 PM EDT, 09/17/2024 (MT Newswires) -- United Airlines' (UAL) plan to retrofit more than 1,000 planes with Starlink and offer Wi-Fi for free almost doubled SpaceX's backlog of Starlink in-flight orders to over 2,500 aircraft, CNBC reported Tuesday, citing Nick Galano, SpaceX director of Starlink aviation sales and partnerships at a conference in Paris. This deal is expected to...
Sector Update: Consumer
Sector Update: Consumer
Sep 17, 2024
01:40 PM EDT, 09/17/2024 (MT Newswires) -- Consumer stocks were mixed Tuesday afternoon, with the Consumer Staples Select Sector SPDR Fund (XLP) shedding 1% and the Consumer Discretionary Select Sector SPDR Fund (XLY) rising 0.6%. Redbook US same-store sales rose by 4.6% from a year earlier in the week ended Sept. 14, slower than a 6.5% year-over-year increase in the...
Novartis Gets FDA Approval for Kisqali to Treat Early Breast Cancer Patients
Novartis Gets FDA Approval for Kisqali to Treat Early Breast Cancer Patients
Sep 17, 2024
01:49 PM EDT, 09/17/2024 (MT Newswires) -- Novartis ( NVS ) said Tuesday that the US Food and Drug Administration has approved Kisqali in combination with an aromatase inhibitor for the adjuvant treatment of people with hormone receptor-positive/human epidermal growth factor receptor 2-negative stage II and III early breast cancer at high risk of recurrence. The approval is based on...
US Steel CEO confident Nippon Steel deal will close 'on its merits'
US Steel CEO confident Nippon Steel deal will close 'on its merits'
Sep 17, 2024
DETROIT (Reuters) -U.S. Steel CEO David Burritt said on Tuesday he was confident Nippon Steel's ( NISTF ) $14.9 billion bid for his company would close on its merits, despite political opposition and concerns raised in a national security review. Burritt, speaking at the Detroit Economic Club, described the review process as very robust but added, we trust the process,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved